Reproterol structure
|
Common Name | Reproterol | ||
|---|---|---|---|---|
| CAS Number | 54063-54-6 | Molecular Weight | 389.41 | |
| Density | 1.47g/cm3 | Boiling Point | 723.4ºC at 760mmHg | |
| Molecular Formula | C18H23N5O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 391.3ºC | |
Use of ReproterolReproterol is a dual acting β2-adrenoceptor agonist and PDE inhibitor. The theophylline constituent of Reproterol inhibits phosphodiesterase activity induced by adenylyl cyclase. Reproterol has the potential for asthma research[1][2]. |
| Name | 7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-1,3-dimethylpurine-2,6-dione |
|---|---|
| Synonym | More Synonyms |
| Description | Reproterol is a dual acting β2-adrenoceptor agonist and PDE inhibitor. The theophylline constituent of Reproterol inhibits phosphodiesterase activity induced by adenylyl cyclase. Reproterol has the potential for asthma research[1][2]. |
|---|---|
| Related Catalog | |
| Target |
β2 adrenoceptor |
| References |
| Density | 1.47g/cm3 |
|---|---|
| Boiling Point | 723.4ºC at 760mmHg |
| Molecular Formula | C18H23N5O5 |
| Molecular Weight | 389.41 |
| Flash Point | 391.3ºC |
| Exact Mass | 389.17000 |
| PSA | 134.54000 |
| InChIKey | WVLAAKXASPCBGT-UHFFFAOYSA-N |
| SMILES | Cn1c(=O)c2c(ncn2CCCNCC(O)c2cc(O)cc(O)c2)n(C)c1=O |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Reproterol [INN:BAN] |
| EINECS 258-956-1 |
| 7-{3-[2-(3,5-dihydroxy-phenyl)-2-hydroxy-ethylamino]-propyl}-1,3-dimethyl-3,7-dihydro-purine-2,6-dione |
| 7-{3-[2-(3,5-dihydroxyphenyl)-2-hydroxyethylamino]-propyl}-theophylline |
| Theophylline,7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl) |
| Reproterolum [INN-Latin] |
| 7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione |
| 7-<3-<2-(3,5-dihydroxyphenyl)-2-hydroxyethylamino>propyl>-theophyllin |
| D 1959 |
| Reproterol |